logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
20/04/2026
Hong Kong stock group CoreTech continues to rise, now up over 100%.
Latest
2 m ago
China Automobile Association: From January to March 2026, the top ten companies in terms of automobile sales sold a total of 5.94 million vehicles.
3 m ago
Guosheng Securities: Net profit in the first quarter was 1.4687 million yuan, a year-on-year decrease of 97.91%
3 m ago
Novartis: Etavopivat achieved two co-primary endpoints in the Phase III HIBISCUS trial for sickle cell disease. In the Phase III trial, etavopivat reduced vaso-occlusive crisis events by 27%. Regulatory approval submission for etavopivat is planned for the second half of 2026.
3 m ago
Fenglong Stock: The deadline for the tender offer has expired and the stock will be suspended from trading starting from April 21st.
3 m ago
Novo Nordisk (NVO.N): Etavopivat achieved two co-primary endpoints in the Phase III HIBISCUS trial for sickle cell disease. In the Phase III trial, etavopivat reduced vascular occlusion crisis events by 27%. Regulatory approval application for etavopivat is planned to be submitted for the first time in the second half of 2026.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.